Skip to main content
ALGORAE PHARMACEUTICALS LIMITED logo

ALGORAE PHARMACEUTICALS LIMITED — Investor Relations & Filings

Ticker · 1AI ISIN · AU0000296022 ASX Professional, scientific and technical activities
Filings indexed 1,159 across all filing types
Latest filing 2005-04-25 Regulatory Filings
Country AU Australia
Listing ASX 1AI

About ALGORAE PHARMACEUTICALS LIMITED

https://algoraepharma.com/

Algorae Pharmaceuticals Limited is a biopharmaceutical company focused on the discovery and development of novel therapeutic solutions for complex medical conditions. The company leverages its proprietary artificial intelligence platform, AlgoraeOS, to streamline the drug discovery process and identify synergistic drug combinations. Its research pipeline primarily targets neurodegenerative diseases and other areas of high unmet clinical need. Key development programs include AI-116, a combination therapy aimed at treating dementia and Alzheimer's disease. By integrating advanced computational modeling with traditional pharmacological research, the company seeks to accelerate the transition of candidates from preclinical stages to clinical trials, optimizing therapeutic efficacy and safety profiles.

Recent filings

Filing Released Lang Actions
Quarterly Newsletter 2 pages ?Kb
Regulatory Filings
2005-04-25 English
9-Year survival of transplanted pig islet cells in Diabetic 2 pages ?Kb
Regulatory Filings
2005-04-05 English
LCT Successfuly Completes Preclinical Diabetes Trial 3 pages ?Kb
Regulatory Filings
2005-04-04 English
Appendix 3B: End of restriction period 8 pages ?Kb
Regulatory Filings
2005-03-17 English
Appendix 3B 8 pages ?Kb
Regulatory Filings
2005-03-17 English
Release from escrow 1 page ?Kb
Regulatory Filings
2005-03-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.